RKER-012, a novel modified ActRIIB ligand trap, attenuated right ventricular cardiomyopathy in a preclinical model of pulmonary arterial hypertension.
Event:
ESC Congress 2024
Topic:
Biotherapies
Session:
Biotherapies in cardiovascular disease: from bench to bedside
/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
